LFMD
LifeMD·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 0
Consensus Rating "Strong Buy"
High Gross Profit Margin
Revenue Beats Expectation
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About LFMD
Lifemd, Inc.
A leading direct-to-patient telehealth company
Healthcare Providers and Services
05/24/1994
12/11/2020
NASDAQ Stock Exchange
304
12-31
Common stock
236 Fifth Avenue, Suite 400, New York, New York
--
LifeMD, Inc., was incorporated in Delaware on May 24, 1994. The company is a direct-to-patient telemedicine company with a range of health and wellness brands. Their subscriptions and products are marketed and sold directly to consumers through advertising on Facebook, Google, Amazon.com, and other social media and e-commerce platforms. Second, they also sell products through third-party partner channels. They sell branded and generic prescription drugs that are then sold directly online and shipped to consumers in all 50 states as well as the District of Columbia and Puerto Rico. They also established a medical group in 50 states to provide virtual consultations for their patients. Since their inception, they have treated approximately 854,000 clients and patients nationwide. They operate their businesses using a proprietary telemedicine technology platform that facilitates compliance relationships between patients, providers and pharmacies.
Earnings Call
Q1/2025
Estimate EPS0.14
Actual EPS0.01
Estimate Revenue62.47M
Actual Revenue65.69M
LifeMD's Q1 2025 Earnings Call: Unpacking Contradictions in Insurance, Telemedicine Growth, and Strategic Focus
May 07,2025 10:26
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS0.18
Actual EPS-0.06
Estimate Revenue66.31M
Actual Revenue62.22M
LifeMD's Q2 2025 Earnings Call: Navigating Contradictions in Insurance Strategy and Customer Acquisition Costs
Aug 05,2025 07:59
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
LFMD has released its 2025 Q3 earnings. EPS was reported at -0.1, versus the expected 0.05, missing expectations. The chart below visualizes how LFMD has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
LFMD has released its 2025 Q3 earnings report, with revenue of 60.17M, reflecting a YoY change of 12.95%, and net profit of -3.56M, showing a YoY change of 25.71%. The Sankey diagram below clearly presents LFMD's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
